Cellectis S.A.
ALCLS.PA · PAR
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | – | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 110.3% | 57% | -16.2% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 93.3% | 85.5% | 81.1% | 100% |
| EBITDA | €0 | -€0 | -€0 | €0 |
| % Margin | 21.9% | -99.6% | -105.9% | 111.5% |
| Net Income | €0 | -€0 | -€0 | €0 |
| % Margin | 1.7% | -141.9% | -170.1% | 46.6% |
| EPS Diluted | 0.006 | -0.24 | -0.18 | 0.066 |
| % Growth | 102.5% | -33.3% | -373.1% | – |
| Operating Cash Flow | -€0 | -€0 | -€0 | -€0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€0 | -€0 | -€0 | -€0 |